Head of Investor Relations
Acadia Pharmaceuticals Inc (ACAD)Head of Investor Relations
Halozyme Therapeutics, Inc. (HALO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Al Kildani is recorded as Head of Investor Relations at Acadia Pharmaceuticals Inc (ACAD) and Head of Investor Relations at Halozyme Therapeutics, Inc. (HALO). Al Kildani has spoken on 9 earnings calls and 1 other investor event across 2 companies, most recently for Acadia Pharmaceuticals Inc on August 12, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Recorded roles and call appearances connecting this person to public companies.
Head of Investor Relations
Head of Investor Relations
Other people whose current roles at this company are on record from its filings.
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
